How can informatization empower the pharmaceutical industry chain?
From the demand side, the stages of agricultural breeding, pharmaceutical R & D and production, pharmaceutical circulation and medical treatment in the pharmaceutical industry are full of industry pain points. In order to improve efficiency, reduce costs and accelerate the circulation efficiency in the industry, enterprises choose to use information technology to enable the whole industrial chain to achieve the purpose of reducing cost and increasing efficiency.
From the supply side, the development of pharmaceutical information industry is mainly supported by information technology. In recent years, China has made a lot of progress in the research and development of AI, big data, Internet of things and other technologies, which can have more opportunities to be applied in the pharmaceutical field and expand its influence in the pharmaceutical industry. In addition, the pharmaceutical information industry is vulnerable to policies. For example, the “two vote system” has reshaped the pharmaceutical circulation pattern, and enterprises have transformed one after another to seek further development space; The state promulgated regulations and policies on “grading treatment” and “electronic medical record”, which shaped the regional and advanced technology of medical informatization construction.
1. There are many pain points in the traditional pharmaceutical industry
The pharmaceutical industry includes agricultural breeding, pharmaceutical R & D and production, pharmaceutical circulation and medical industry, and finally faces the terminal market. There are many pain points in the traditional sub industries. For example, the agricultural seed breeding industry at the upstream food and drug source is vulnerable to geological geography, weather and climate, natural disasters, crop habits, diseases and pests and other factors, resulting in low yield and low efficiency. Pharmaceutical R & D and production links are faced with problems such as long drug R & D cycle and high capital consumption. There are some problems in the circulation of medicine, such as information blockage and lag among the participants of the whole market. The medical industry ultimately faces the terminal market, which is vulnerable to market environment and policies. Many pain points need to seek new means to eliminate them one by one.
2. The use of informatization to empower the pharmaceutical industry is conducive to eliminating pain points, accelerating the circulation efficiency of the whole industry and showing the good development prospects of the industry
New technologies and services such as big data, Internet of things, artificial intelligence and cloud platform constitute multiple application scenarios in the pharmaceutical industry. For example, the use of Internet of things, big data and other technologies can monitor the variables affecting crop output in real time and in the whole process, and provide product quality traceability services. In pharmaceutical R & D and production, the use of big data, AI and other technologies can help pharmaceutical enterprises quickly screen compounds and promote the development of R & D links to high efficiency and quality. In addition, the use of MES, Cloud Architecture and other technical services in the field of pharmaceutical circulation can establish information circulation channels among market participants.
Enabling the pharmaceutical industry with information technology will help eliminate the pain points of the industry, bring higher quality services to market participants, reduce costs and increase efficiency for enterprises, so as to promote the healthy development of the industry. In the future, informatization will still be the main business development direction of pharmaceutical market participants.
